Related Experiment Video
Updated: Mar 31, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
What can we learn from oncology surgical trials?
Serge Evrard1, Pippa McKelvie-Sebileau1, Cornelis van de Velde2
1Institut Bergonie, 229 cours de l'Argonne, Bordeaux 33000, France.
High-quality surgical oncology trials face challenges like poor recruitment and evolving treatments. This analysis examines trial failures and suggests improving prospective methodologies for better cancer-surgery evaluation.
Area of Science:
- Oncology
- Surgical Oncology
- Clinical Trials
Background:
- Prospective clinical trials in surgical oncology are crucial but difficult to conduct effectively.
- Many trials fail due to issues like insufficient patient enrollment, lack of clinician engagement, and treatment advancements over long study periods.
Purpose of the Study:
- To examine failures in published surgical oncology trials.
- To critically assess established prospective trial methodologies (Phase 0-IV, comparative audits).
- To propose improvements for future cancer-surgery practice evaluation.
Main Methods:
- Review and analysis of published surgical oncology trial failures.
- Critical assessment of existing prospective trial designs and methodologies.
- Discussion of potential enhancements for future clinical trial frameworks.
Main Results:
- Identified common reasons for surgical oncology trial failures.
- Highlighted limitations in current prospective trial methodologies.
- Provided insights into optimizing trial design and execution.
Conclusions:
- Addressing recruitment, clinician interest, and treatment evolution is key to trial success.
- Established prospective trial methodologies need critical evaluation and potential adaptation.
- Improved trial design and execution are essential for advancing cancer-surgery practice.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Treatment Resistant Cancers
Clinical Trials: Overview
Treatment Resistent Cancers
Cancer Therapies
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...